Company Filing History:
Years Active: 2012
Title: Innovations in Molecular Imprinted Polymers by Nicholas O. Krogh
Introduction: Nicholas O. Krogh is an accomplished inventor based in Virum, DK, known for his contributions to the field of molecular imprinted polymers (MIPs). With a focus on improving the efficiency and efficacy of MIP preparation, Krogh's work has significant implications for diagnostic, analytical, and therapeutic applications.
Latest Patents: Krogh holds a patent for the "Preparation of molecular imprinted polymers," which outlines a method for enhancing the preparation of MIP particles. This innovative process involves enriching initial compositions of insoluble MIP particles, ensuring that only those particles binding to a specific target molecule remain in the final product. Through chromatographic methods or agglutination, Krogh's technique effectively separates non-binding and weakly binding particles from the desired composition. Additionally, his patent describes the micronization of raw MIP particles to increase the exposure of binding sites, which can subsequently enhance the therapeutic efficacy of orally administered drugs that bind cholesterol, bile acids, and bile acid salts in the gastrointestinal tract.
Career Highlights: Nicholas O. Krogh's career is marked by his role at Mipsalus ApS, where he has been instrumental in advancing research and applications in the field of molecular imprinted polymers. His innovative techniques and dedication to improvement have contributed to the broader understanding and utilization of MIPs within the scientific community.
Collaborations: Throughout his career, Krogh has collaborated with esteemed colleagues, including Jesper Svenning Kristensen and Klaus Gregorius Nielsen. These partnerships have fostered innovative ideas and furthered research initiatives, strengthening the impact of their work in molecular imprinting technology.
Conclusion: Nicholas O. Krogh stands out as a prominent inventor in the field of molecular imprinted polymers. His unique approach to MIP preparation not only enhances the efficiency of binding but also opens new avenues for therapeutic applications. As the landscape of innovation continues to evolve, Krogh's contributions will likely play a crucial role in shaping the future of diagnostic and therapeutic solutions.